799 related articles for article (PubMed ID: 26828775)
1. New signal transduction paradigms in anthracycline-induced cardiotoxicity.
Ghigo A; Li M; Hirsch E
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1916-25. PubMed ID: 26828775
[TBL] [Abstract][Full Text] [Related]
2. Anthracycline Chemotherapy and Cardiotoxicity.
McGowan JV; Chung R; Maulik A; Piotrowska I; Walker JM; Yellon DM
Cardiovasc Drugs Ther; 2017 Feb; 31(1):63-75. PubMed ID: 28185035
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?
Sawyer DB; Peng X; Chen B; Pentassuglia L; Lim CC
Prog Cardiovasc Dis; 2010; 53(2):105-13. PubMed ID: 20728697
[TBL] [Abstract][Full Text] [Related]
5. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
6. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
[TBL] [Abstract][Full Text] [Related]
7. Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron.
Simůnek T; Stérba M; Popelová O; Adamcová M; Hrdina R; Gersl V
Pharmacol Rep; 2009; 61(1):154-71. PubMed ID: 19307704
[TBL] [Abstract][Full Text] [Related]
8. Anthracycline cardiotoxicity in long-term survivors of childhood cancer.
Scully RE; Lipshultz SE
Cardiovasc Toxicol; 2007; 7(2):122-8. PubMed ID: 17652816
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity.
Chung WB; Youn HJ
Korean J Intern Med; 2016 Jul; 31(4):625-33. PubMed ID: 27378126
[TBL] [Abstract][Full Text] [Related]
10. The tell-tale heart: molecular and cellular responses to childhood anthracycline exposure.
Lindsey ML; Lange RA; Parsons H; Andrews T; Aune GJ
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1379-89. PubMed ID: 25217655
[TBL] [Abstract][Full Text] [Related]
11. Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities.
Vejpongsa P; Yeh ET
J Am Coll Cardiol; 2014 Sep; 64(9):938-45. PubMed ID: 25169180
[TBL] [Abstract][Full Text] [Related]
12. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention.
Henriksen PA
Heart; 2018 Jun; 104(12):971-977. PubMed ID: 29217634
[TBL] [Abstract][Full Text] [Related]
13. Genotyping the risk of anthracycline-induced cardiotoxicity.
Deng S; Wojnowski L
Cardiovasc Toxicol; 2007; 7(2):129-34. PubMed ID: 17652817
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity of Cancer Treatments: Focus on Anthracycline Cardiomyopathy.
Nishi M; Wang PY; Hwang PM
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2648-2660. PubMed ID: 34587760
[TBL] [Abstract][Full Text] [Related]
15. New iron chelators in anthracycline-induced cardiotoxicity.
Kaiserová H; Simunek T; Sterba M; den Hartog GJ; Schröterová L; Popelová O; Gersl V; Kvasnicková E; Bast A
Cardiovasc Toxicol; 2007; 7(2):145-50. PubMed ID: 17652820
[TBL] [Abstract][Full Text] [Related]
16. Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs).
Bozza WP; Takeda K; Alterovitz WL; Chou CK; Shen RF; Zhang B
AAPS J; 2021 Mar; 23(2):44. PubMed ID: 33719006
[TBL] [Abstract][Full Text] [Related]
17. [Cardiotoxicity of anthracyclines].
Costache II; Petriş A
Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1200-7. PubMed ID: 22276470
[TBL] [Abstract][Full Text] [Related]
18. An introduction to the metabolic determinants of anthracycline cardiotoxicity.
Menna P; Recalcati S; Cairo G; Minotti G
Cardiovasc Toxicol; 2007; 7(2):80-5. PubMed ID: 17652809
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 contributes to adriamycin-induced cardiotoxicity via up-regulating autophagy.
Luo P; Zhu Y; Chen M; Yan H; Yang B; Yang X; He Q
Toxicol Lett; 2018 Aug; 292():115-122. PubMed ID: 29715512
[TBL] [Abstract][Full Text] [Related]
20. Complications of chemotherapy, a basic science update.
Mazevet M; Moulin M; Llach-Martinez A; Chargari C; Deutsch E; Gomez AM; Morel E
Presse Med; 2013 Sep; 42(9 Pt 2):e352-61. PubMed ID: 23972551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
